Previous 10 | Next 10 |
2023-11-13 12:13:48 ET More on DexCom, Novo, etc. Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise Eli Lilly and Company (LLY) Presents at UBS Biopharma 2023 Confe...
2023-11-10 16:05:35 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-11-09 14:47:34 ET Summary Alphatec Holdings, Inc.'s focus on growth rather than improving margins raises caution for investors. Despite strong revenue growth, the company continues to experience substantial losses and slow progress on margin improvements. The recent share...
2023-11-07 14:46:19 ET More on Zimmer Biomet Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence Zimmer Biomet: Knees The Key Growth Lever, Reiterate Buy On Long-Term Value Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy ...
2023-11-07 14:40:24 ET Zimmer Biomet Holdings, Inc. (ZBH) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Keri Mattox – Chief Communications and Administration Officer Ivan Tornos – President and Chief Executive Officer...
2023-11-07 06:31:57 ET More on Zimmer Biomet Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence Zimmer Biomet: Knees The Key Growth Lever, Reiterate Buy On Long-Term Value Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy ...
Zimmer Biomet Announces Third Quarter 2023 Financial Results PR Newswire Third quarter net sales of $1.754 billion increased 5.0% and 4.7% on a constant currency 1 basis Third quarter diluted earnings per share were $0.77 ; adjusted 1 diluted earnings per s...
Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...
Zimmer Biomet Holdings Inc. (ZBH) is expected to report $1.59 for Q3 2023
2023-11-06 12:27:58 ET More on Zimmer Biomet Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence Zimmer Biomet: Knees The Key Growth Lever, Reiterate Buy On Long-Term Value Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy ...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...